Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Clinical trial NCT02402920 · COMPLETED

Trial details

NCT number: NCT02402920
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Carcinoma Limited Stage Small Cell Lung Carcinoma Neuroendocrine Neoplasm

Start date: 2015-07-22
Primary completion: 2025-12-23
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.